Skip to Content

'
Simona F Shaitelman, M.D., Ed.M.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2006 Harvard Medical School, Boston, MA, MD, Medicine
2005 Harvard Graduate School of Education, Cambridge, MA, Ed.M., Medical Education and Adult Learning
2000 Consejo Superior de Investigaciones Cientificas, Barcelona, Spain, Fulbright Scholar, History of Medicine
1999 Princeton University, Princeton, NJ, AB, Magna Cum Laude, History

Postgraduate Training

1/2009-6/2011 Clinical Residency, Radiation Oncology, William Beaumont Hospital, Royal Oak, MI
7/2007-12/2008 Clinical Residency, Radiation Oncology, Columbia-New York Presbyterian Hospital, New York, NY
7/2006-6/2007 Clinical Internship, Internal Medicine, The Mount Sinai Hospital, New York, NY

Honors and Awards

2010 Merit Award, ASCO Genitourinary Symposium, American Society of Clinical Oncology
2010 Resident Travel Grant Award, American Brachytherapy Society
2010 Scholarship, San Antonio Breast Cancer Symposium, American Association for Cancer Research
2002 Latin American Studies Travel Grant, David Rockefeller Center, Harvard University
2002 Paul Dudley White Traveling Fellowship, Harvard Medical School
1999-2000 Fulbright Scholar, U.S. Department of State

Selected Publications

Peer-Reviewed Original Research Articles

1. Shirvani SM, Jiang J, Likhacheva A, Hoffman KE, Shaitelman SF, Caudle A, Buchholz TA, Giordano SH, Smith BD. Trends in local therapy utilization and cost for early-stage breast cancer in older women: Implications for payment and policy reform. Int J Radiat Oncol Biol Phys. In Press.
2. Ovalle V, Strom EA, Godby J, Shaitelman SF, Stauder MC, Amos RA, Kuerer HM, Woodward WA, Hoffman KE. Proton partial-breast irradiation for early-stage cancer: Is it really so costly? Int J Radiat Oncol Biol Phys 95(1):49-51, 5/2016. PMID: 27084625.
3. Huo J, Giordano SH, Smith BD, Shaitelman SF, Smith GL. Contemporary Toxicity Profile of Breast Brachytherapy Versus External Beam Radiation After Lumpectomy for Breast Cancer. Int J Radiat Oncol Biol Phys 94(4):709-718, 3/2016. PMID: 26972643.
4. Shaitelman SF, Lin HY, Smith BD, Shen Y, Bedrosian I, Marsh GD, Bloom ES, Vicini FA, Buchholz TA, Babiera GV. Practical implications of hte publication of consensus guidelines by the American Society for Radiation Oncology: accelerated partial breast irradiation and the National Cancer Data Base. Int J Radiat Oncol Biol Phys 94(1):338-348, 2/1/2016. e-Pub 10/31/2015. PMID: 26853342.
5. Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HM. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. J Clin Oncol. e-Pub 1/2016. PMID: 26811528.
6. Grant SR, Walker GV, Koshy M, Shaitelman SF, Klopp AH, Frank SJ, Pugh TJ, Allen PK, Mahmood U. Impact of insurance status on radiation treatment modality selection among potential candidates for prostate, breast or gynecologic brathytherapy. Int J Radiat Oncol Biol Phys 93(5):968-75, 12/1/2015. e-Pub 8/28/2015. PMID: 26452570.
7. Bishop AJ, Ensor J, Moulder SL, Shaitelman SF, Edson MA, Whitman GJ, Bishnoi S, Hoffman KE, Stauder MC, Valero V, Buchholz TA, Ueno NT, Babiera G, Woodward WA. Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy. Cancer 121(24):4324-32, 12/15/2015. e-Pub 9/8/2015. PMID: 26348887.
8. Pan HY, Shaitelman SF, Perkins GH, Schlembach PJ, Woodward WA, Smith BD. Implementing a real-time electronic data capture system to improve clinical documentation in radiation oncology. J Am Coll Radiol. e-Pub 12/2015. PMID: 26681164.
9. Voss RK, Cromwell KD, Chiang YJ, Armer JM, Ross MI, Lee JE, Gershenwald JE, Stewart BR, Shaitelman SF, Cormier JN. The long-term risk of upper-extremity lymphedema is two-fold higher per lymph node removed in breast cancer patients than in melanoma patients. J Surg Oncol 112(8):834-40, 12/2015. e-Pub 10/18/2015. PMCID: PMC4715673.
10. Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, Chronowski GM, Dvorak T, Grade E, Hoffman KE, Kelly P, Ludwig M, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Baumann D, Thompson AM, Amaya D, Davis T, Guerra W, Hamblin L, Hortobagyi G, Hunt KK, Buchholz TA, Smith BD. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. JAMA Oncol 1(7):931-41, 10/1/2015. e-Pub 8/2015. PMCID: PMC4635441.
11. Shah C, Vicini FA, Berry S, Julian TB, Wilkinson JB, Shaitelman SF, Khan A, Finkelstein SE, Goldstein N. Ductal carcinoma in situ of the breast: evaluating the role of radiation therapy in the management and attempts to identify low-risk patients. Am J Clin Oncol 38(5):526-33, 10/2015. e-Pub 7/17/2014. PMID: 25036472.
12. Swisher SK, Vila J, Tucker SL, Bedrosian I, Shaitelman SF, Litton JK, Smith BD, Caudle AS, Kuerer HM, Mittendorf EA. Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy. Ann Surg Oncol. e-Pub 10/2015. PMID: 26511263.
13. Shaitelman SF, Tereffe W, Dogan BE, Hess KR, Caudle AS, Valero V, Stauder MC, Krishnamurthy S, Candelaria RP, Strom EA, Woodward WA, Hunt KK, Buchholz TA, Whitman GJ. Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment. Int J Radiat Oncol Biol Phys 93(1):102-10, 9/2015. e-Pub 5/2015. PMID: 26279028.
14. Lautner M, Lin H, Shen Y, Parker C, Kuerer H, Shaitelman S, Babiera G, Bedrosian I. Disparities in the use of breast-conserving therapy among patients with early-stage breast cancer. JAMA Surg 150(8):778-86, 8/1/2015. e-Pub 6/17/2015. PMID: 26083835.
15. Strom EA, Amos RA, Shaitelman SF, Kerr MD, Hoffman KE, Smith BD, Tereffe W, Stauder MC, Perkins GH, Amin MD, Wang X, Poenisch F, Ovalle V, Buchholz TA, Babiera G, Woodward WA. Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique. Pract Radiat Oncol 5(4). e-Pub 3/2015. PMID: 25804105.
16. Wobb JL, Chen PY, Shah C, Moran MS, Shaitelman SF, Vicini FA, Mbah AK, Lyden M, Beitsch P. Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 91(2):312-318, 2/1/2015. e-Pub 11/11/2014. PMID: 25446607.
17. Shaitelman SF, Cromwell KD, Rasmussen JC, Stout NL, Armer JM, Lasinski BB, Cormier JN. Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin 65(1):55-81, Jan-Feb, 1/2015. e-Pub 11/19/2014. PMID: 25410402.
18. Thaker NG, Hoffman KE, Stauder MC, Shaitelman SF, Strom EA, Tereffe W, Smith BD, Perkins GH, Huo L, Munsell MF, Pusztai L, Buchholz TA, Woodward WA. The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer. Springerplus 4:36, 2015. e-Pub 1/30/2015. PMCID: PMC4318826.
19. Shaitelman S, Buchholz TA, Hunt KK, Hortobagyi G, Schlembach P, Arzu I, Bloom E, Chronowski G, Dvorak T, Grade Hoffman K, Perkins G, Reed V, Shah S, Stauder M, Strom E, Tereffe W, Woodward W, Smith BD. Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at 6 months comparred to conventionally fractionated whole breast irradiation: results of a randomized trial. Proceedings of the American Society for Radiation Oncology 56th Annual Meeting 90(5):1264, 9/2014. PMID: 95539386.
20. Mittendorf EA, Caudle AS, Yang W, Krishnamurthy S, Shaitelman S, Chavez-MacGregor M, Woodward WA, Bedrosian I, Kuerer HM, Hunt KK. Implementation of the American College of Surgeons Oncology Group Z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy? Ann Surg Oncol 21(8):2468-73, 8/2014. e-Pub 5/20/2014. PMID: 24841348.
21. Haynes AB, Bloom ES, Bedrosian I, Kuerer HM, Hwang RF, Munsell MF, Chemaly RF, Graviss LS, Caudle AS, Hunt KK, Tereffe W, Shaitelman SF, Babiera GV. Timing of Infectious Complications Following Breast-Conserving Therapy with Catheter-Based Accelerated Partial Breast Irradiation. Ann Surg Oncol 21(8):2512-2516, 8/2014. e-Pub 4/16/2014. PMID: 24736987.
22. Rueth NM, Lin HY, Bedrosian I, Shaitelman SF, Ueno NT, Shen Y, Babiera G. Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer Database. J Clin Oncol 32(19):2018-2024, 7/1/2014. e-Pub 6/2/2014. PMCID: PMC4067942.
23. Shaitelman SF, Khan AJ, Woodward WA, Arthur DW, Cuttino LW, Bloom ES, Shah C, Freedman GM, Wilkinson JB, Babiera GV, Julian TB, Vicini FA. Shortened radiation therapy schedules for early stage breast cancer: A review of hypofractionated whole breast irradiation and accelerated partial breast irradiation. Breast J 20(2):131-46, Mar-Apr, 3/2014. e-Pub 1/31/2014. PMID: 24479632.
24. MacDermed DM, Houtman KM, Thang SH, Allen PK, Caudle AS, Gainer SM, Hunt KK, Perkins GH, Shaitelman SF, Smith BD, Strom EA, Tereffe W, Woodward WA, Buchholz TA, Hoffman KE. Therapeutic radiation dose delivered to the low axilla during whole breast radiotherapy in the prone position: implications for targeting the undissected axilla. Pract Radiat Oncol 4(2):116-122, Mar-Apr, 3/2014. e-Pub 7/12/2013. PMID: 24890352.
25. Wang X, Zhang X, Li X, Amos RA, Shaitelman SF, Hoffman K, Howell R, Salehpour M, Zhang SX, Sun TL, Smith B, Tereffe W, Perkins GH, Buchholz TA, Strom EA, Woodward WA. Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits? Br J Radiol 86(1029):20130176, 9/2013. e-Pub 5/31/2013. PMCID: PMC3755395.
26. Wilkinson JB, Beitsch PD, Shah C, Arthur D, Haffty BG, Wazer DE, Keisch M, Shaitelman SF, Lyden M, Chen PY, Vicini FA. Evaluation of Current Consensus Statement Recommendations for Accelerated Partial Breast Irradiation: A Pooled Analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite(®) Registry Trial Data. Int J Radiat Oncol Biol Phys 85(5):1179-85, 4/1/2013. e-Pub 11/22/2012. PMID: 23182700.
27. Wilkinson JB, Vicini FA, Shah C, Shaitelman S, Jawad MS, Ye H, Kestin LL, Goldstein NS, Martinez AA, Benitez P, Chen PY. Twenty-Year Outcomes after Breast-Conserving Surgery and Definitive Radiotherapy for Mammographically Detected Ductal Carcinoma In Situ. Ann Surg Oncol 19(12):3785-91, 11/2012. e-Pub 5/30/2012. PMID: 22644510.
28. Shaitelman SF, Wilkinson JB, Kestin LL, Ye H, Goldstein NS, Martinez AA, Vicini FA. Long-Term Outcome in Patients with Ductal Carcinoma in situ Treated with Breast-Conserving Therapy: Implications for Optimal Follow-up Strategies. Int J Radiat Oncol Biol Phys 83(3):e305-12, 7/1/2012. e-Pub 3/13/2012. PMID: 22417804.
29. Shaitelman SF, Vicini FA, Grills IS, Martinez AA, Yan D, Kim LH. Differences in Effective Target Volume Between Various Techniques of Accelerated Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 82(1):30-6, 1/1/2012. e-Pub 11/1/2010. PMID: 21050674.
30. Shaitelman SF, Grills IS, Kestin LL, Ye H, Nandalur S, Huang J, Vicini FA. Rates of Second Malignancies After Definitive Local Treatment for Ductal Carcinoma In Situ of the Breast. Int J Radiat Oncol Biol Phys 81(5):1244-51, 12/1/2011. e-Pub 10/27/2010. PMID: 21030159.
31. Shah C, Wilkinson JB, Shaitelman S, Grills I, Wallace M, Mitchell C, Vicini F. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma. Int J Radiat Oncol Biol Phys 81(4):e547-541, 11/15/2011. e-Pub 6/2/2011. PMID: 21640491.
32. Wilkinson JB, Reid RE, Shaitelman SF, Chen PY, Mitchell CK, Wallace MF, Marvin KS, Grills IS, Margolis JM, Vicini FA. Outcomes of Breast Cancer Patients With Triple Negative Receptor Status Treated With Accelerated Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 81(3):S227-S228, 11/1/2011. e-Pub 2/23/2011. PMID: 21345613.
33. Shaitelman SF, Kim LH, Grills IS, Chen PY, Ye H, Kestin LL, Yan D, Vicini FA. Predictors of Long-Term Toxicity Using Three-Dimensional Conformal External Beam Radiotherapy To Deliver Accelerated Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 81(3):788, 11/1/2011. e-Pub 10/8/2010. PMID: 20933342.
34. Shaitelman SF, Kim LH, Yan D, Martinez AA, Vicini FA, Grills IS. Continuous arc rotation of the couch therapy for the delivery of accelerated partial breast irradiation: a treatment planning analysis. Int J Radiat Oncol Biol Phys 80(3):771-8, 7/1/2011. e-Pub 6/30/2010. PMID: 20584586.
35. Beitsch PD, Shaitelman SF, Vicini FA. Accelerated partial breast irradiation. J Surg Oncol 103(4):362-8, 3/15/2011. PMID: 21337572.
36. Théberge V, Whelan T, Shaitelman SF, Vicini FA. Altered fractionation: rationale and justification for whole and partial breast hypofractionated radiotherapy. Semin Radiat Oncol 21(1):55-65, 1/2011. PMID: 21134655.

Editorials

1. Shaitelman SF. Sounding a warning bell? Documentation of the increased utilization of accelerated partial breast irradiation. J Natl Cancer Inst 104(1):5-7, 1/4/2012. e-Pub 12/16/2011. PMID: 22180644.

Abstracts

1. Mamounas EP, Bandos H, White JR, Julian TB, Kahn AJ, Shaitelman SF, Torres MA, McCloskey SA, Vicini FA, Ganz PA, Paik S, Gupta N, Costantino JP, Curran Jr WJ, Wolmark N. NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes who are ypN0 after neoadjuvant chemotherapy (NC). Proceedings of the 2015 ASCO Annual Meeting. In Press.
2. Shaitelman SF, Buchholz TA, Hunt KK, Hortobagyi GN, Schlembach P, Arzu I, Bloom E, Chronowski G, Dvorak T, Grade E, Hoffman KE, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Smith BD. Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at six months compared to conventionally fractionated whole breast irradiation: results of a randomized trial. Int J Radiat Oncol Biol Phys 90(5):1264, 12/2014.

Letters to the Editor

1. Kim L, Shaitelman S. What is the target volume for preoperative accelerated partial breast irradiation (APBI)? In regards to Nichols et al. (Int J Radiat Oncol Biol Phys 2010;77:197-202) and Palta et al. (Int J Radiat Oncol Biol Phys 2010, in Press). Int J Radiat Oncol Biol Phys 80(1):314-5; author reply 315-6, 5/1/2011. PMID: 21481727.

Last updated: 4/19/2016